Élie Haddad, MD, PhD
Theme 1& 2 Participant
Eric J. Arts, PhD
Professor and Chair, Department of Microbiology and Immunology, Schulich School of Mecidine & Dentistry, Western University, London, On, Canada
Director, Ugandan CFAR Laboratories
Michael M. Lederman,MD
Scott R. Inkley Professor of Medicine, Professor of Pathology, Microbiology, Molecular Biology and Biomedical Ethics, School of Medicine, Case Western Reserve University, Cleveland, Oh, United States
Guido Poli, MD
Professor and Head, AIDS Immunopathogenesis Unit, Division of Immunology, Transplantation and Infectious Diseases, Vita-Salute San Raffaele University School of Medicine & San Raffaele Scientifuc Institute, Milan, Italy
Guido Silvestri, MD
Eminent Scholar in Comparative Pathology, Georgia Research AllianceProfessor of pathology and Laboratory Medicine, School of Medicine, Emory University, Chief, Division of Microbiology & Immunology, Yerkes National Primate Research Center, Atlanta, GA, United States
Community Advisory Board
Clinical Trial Network
The CIHR Canadian HIV Trials Network (CTN) is an innovative partnership of clinical investigators, physicians, nurses, people living with HIV, pharmaceutical manufacturers and others that facilitate HIV clinical trials of the highest scientific and ethical standards.
BioLegend is a leading developer of cutting-edge antibodies and reagents provided for biomedical research worldwide. Their objective is to accelerate research and discovery by offering the highest quality products at an outstanding value, along with superior customer service and technical support.
Merck's vision is to make a difference in the lives of people globally through their innovative medicines, vaccines, and animal health products. They are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.